BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28483174)

  • 1. [Impact of a Multimodal Intervention on the Psychological Profile of Schizophrenic and Bipolar I Patients: A Study of PRISMA Program].
    Díaz-Zuluaga AM; Vargas C; Duica K; Richard S; Palacio JD; Agudelo Berruecos Y; Ospina S; López-Jaramillo C
    Rev Colomb Psiquiatr; 2017; 46(2):56-64. PubMed ID: 28483174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressed Emotions, Burden and Family Functioning in Schizophrenic and Bipolar I Patients of a Multimodal Intervention Program: PRISMA].
    Ramírez A; Palacio JD; Vargas C; Díaz-Zuluaga AM; Duica K; Agudelo Berruecos Y; Ospina S; López-Jaramillo C
    Rev Colomb Psiquiatr; 2017; 46(1):2-11. PubMed ID: 28193369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and Socio-occupational Intervention in Bipolar and Schizophrenic Patients within a Multimodal Intervention Program- PRISMA.
    Díaz Zuluaga AM; Duica K; Ruiz Galeano C; Vargas C; Agudelo Berruecos Y; Ospina S; López-Jaramillo C
    Rev Colomb Psiquiatr (Engl Ed); 2018; 47(1):4-12. PubMed ID: 29428121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: a randomized clinical trial.
    West AE; Weinstein SM; Peters AT; Katz AC; Henry DB; Cruz RA; Pavuluri MN
    J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1168-78, 1178.e1. PubMed ID: 25440307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years.
    Lam DH; Hayward P; Watkins ER; Wright K; Sham P
    Am J Psychiatry; 2005 Feb; 162(2):324-9. PubMed ID: 15677598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the experience of caregiving in bipolar affective disorder and schizophrenia.
    Grover S; Chakrabarti S; Aggarwal M; Avasthi A; Kulhara P; Sharma S; Khehra N
    Int J Soc Psychiatry; 2012 Nov; 58(6):614-22. PubMed ID: 21873293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
    Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
    Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A web-based preventive intervention program for bipolar disorder: outcome of a 12-months randomized controlled trial.
    Barnes CW; Hadzi-Pavlovic D; Wilhelm K; Mitchell PB
    J Affect Disord; 2015 Mar; 174():485-92. PubMed ID: 25554993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving functional outcomes in early-stage bipolar disorder: The protocol for the REsearch into COgnitive and behavioural VERsatility trial.
    Cotton SM; Berk M; Jackson H; Murray G; Filia K; Hasty M; Chanen A; Davey C; Nelson B; Ratheesh A; MacNeil C
    Early Interv Psychiatry; 2019 Dec; 13(6):1470-1479. PubMed ID: 30740882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study.
    Mizuno Y; Hofer A; Suzuki T; Frajo-Apor B; Wartelsteiner F; Kemmler G; Saruta J; Tsukinoki K; Mimura M; Fleischhacker WW; Uchida H
    Schizophr Res; 2016 Aug; 175(1-3):148-153. PubMed ID: 27185483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioural treatment of first diagnosis bipolar disorder.
    Jones SH; Burrell-Hodgson G
    Clin Psychol Psychother; 2008; 15(6):367-77. PubMed ID: 19115455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between psychosocial adjustment and executive function in patients with bipolar disorder and schizophrenia in remission: the mediating and moderating effects of insight.
    Yen CF; Cheng CP; Huang CF; Ko CH; Yen JY; Chang YP; Chen CS
    Bipolar Disord; 2009 Mar; 11(2):190-7. PubMed ID: 19267701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.
    Martínez-Arán A; Penadés R; Vieta E; Colom F; Reinares M; Benabarre A; Salamero M; Gastó C
    Psychother Psychosom; 2002; 71(1):39-46. PubMed ID: 11740167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
    Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
    BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model].
    Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
    Encephale; 2008 Dec; 34(6):597-605. PubMed ID: 19081457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.